💔 #HFpEF is more than a heart issue—it’s a multisystem syndrome driven by inflammation, metabolism & organ crosstalk. Current drugs help some, but precision, multi-organ therapies are the future. Read that in #JCTR#CardioTwitter 👉https://t.co/VDMbfTcMFI @ELaraPezzi#ISCTR
Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive Overview @jsluijter#AHAJournals https://t.co/HPyYwuWuRS
✨ Wondering where the next-gen #Cardiovascular therapies will come from?
💡 Proud to be part of the CARE (Cardiovascular Regenerative & Reparative Medicine) Nucleus, ESC Working Group!
@ESCWGCAREChair#ESCCongress
Join Here...
https://t.co/jesDY4z0zi
Improving streamlined remote monitoring in #HF with #HeartLogic: workflow redesign led to a decrease in HeartLogic enablement time and reduction in delayed data transmissions 👉#JCTR https://t.co/J35NcWD7GD @ELaraPezzi#ISCTR
Living human myocardial slices hold translational potential for predicting the reversibility of chemotherapy-induced cardiotoxicity #AHAJournals@jsluijter@jpvantintelen@UMCUtrecht @CirculatHealth @Joost_sluijter https://t.co/3ZgcEY8ncf
#magnesium depletion score #MDS is a novel #CVD risk factor, but is it also and specifically for #PAD? in #JCTR a population study identifies an increased risk for the elderly. Read the data from the National Health and Nutrition Examination Survey 👉https://t.co/38Uptuu5jg
Transplanting cardiac microtissues #CMTs with a triple immunosuppression protocol show better engraftment and longer survival in a #heartInjury model. A promising study just published in #JCTR by @JSluijter's group! https://t.co/w5Mlyxogyp @ELaraPezzi#ISCTR
Human cardiac microtissues have improved engraftment and survival in the heart upon injection vs single cells! A great collaborative achievement and real pleasure to work with this team. Enjoy reading!
@UMCU_Intl https://t.co/gCqJ6wIUVS
https://t.co/0TJGSfpcAJ
Interested in the role of Extracellular Vesicles in the cardiovascular system?
See our recent work to provide a stepping stone towards more understanding!
https://t.co/D8gTBAhOcu
It's this time of the year! Announcing the best 2024 #JCTR paper: Gut Microbiota as Predictive Biomarker for Chronic Heart Failure in Patients with Different Nutritional Risk by Yang et al. https://t.co/uP2NC6Dyw0 Congratulations to the Authors!
What if you could permanently regulate your #LDL cholesterol levels? Read on #JCTR the promising application of #CRISPRCas9 editing strategy to help prevent atherosclerosis and CVD 👉https://t.co/bG8Vy2xEyL #ISCTR@ELaraPezzi
Are you interested in extracellular vesicles and CRISPR gene editing? Check out the post-doc position on EV-mediated CRISPR delivery for treating a rare cardiomyopathy @UMCUtrecht
Don’t miss your chance to apply by January 12th!
https://t.co/aC5KoBaTzM
@ISEV_Journals@NLSEV_